Literature DB >> 16802861

Publishing negative results: the problem of publication bias.

Sara Rockwell, Bruce F Kimler, John E Moulder.   

Abstract

Mesh：

Year:  2006        PMID： 16802861     DOI： 10.1667/RR3573.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN： 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  9 in total

1.  Fighting publication bias: introducing the Negative Results section.

Authors:  Ulrich Dirnagl; Martin Lauritzen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07       Impact factor: 6.200

Review 2.  Metallothionein and the biology of aging.

Authors:  William R Swindell
Journal:  Ageing Res Rev       Date:  2010-10-08       Impact factor: 10.895

3.  A call for transparent reporting to optimize the predictive value of preclinical research.

Authors:  Story C Landis; Susan G Amara; Khusru Asadullah; Chris P Austin; Robi Blumenstein; Eileen W Bradley; Ronald G Crystal; Robert B Darnell; Robert J Ferrante; Howard Fillit; Robert Finkelstein; Marc Fisher; Howard E Gendelman; Robert M Golub; John L Goudreau; Robert A Gross; Amelie K Gubitz; Sharon E Hesterlee; David W Howells; John Huguenard; Katrina Kelner; Walter Koroshetz; Dimitri Krainc; Stanley E Lazic; Michael S Levine; Malcolm R Macleod; John M McCall; Richard T Moxley; Kalyani Narasimhan; Linda J Noble; Steve Perrin; John D Porter; Oswald Steward; Ellis Unger; Ursula Utz; Shai D Silberberg
Journal:  Nature       Date:  2012-10-11       Impact factor: 49.962

4.  Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?

Authors:  Xiangyi Kong; Yu Wang; Congxin Dai; Wenbin Ma; Renzhi Wang
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

5.  CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.

Authors:  Xiangyi Kong; Yu Wang; Shuai Liu; Bing Xing; Yi Yang; Yongning Li; Zuyuan Ren; Changbao Su; Wenbin Ma; Renzhi Wang
Journal:  Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.590

6.  Survivin overexpression is potentially associated with pituitary adenoma invasiveness.

Authors:  Xiangyi Kong; Shun Gong; Lijuan Su; Xinqi Cheng; Honglei Li; Tingting You; Yanguo Kong
Journal:  Oncotarget       Date:  2017-11-10

7.  On the value of preprints: An early career researcher perspective.

Authors:  Sarvenaz Sarabipour; Humberto J Debat; Edward Emmott; Steven J Burgess; Benjamin Schwessinger; Zach Hensel
Journal:  PLoS Biol       Date:  2019-02-21       Impact factor: 8.029

Review 8.  CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.

Authors:  Xiangyi Kong; Jian Guan; Wenbin Ma; Yongning Li; Bing Xing; Yi Yang; Yu Wang; Jun Gao; Junji Wei; Yong Yao; Zhiqin Xu; Wanchen Dou; Wei Lian; Changbao Su; Zuyuan Ren; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.

Authors:  Xiangyi Kong; Wenbin Ma; Yongning Li; Yu Wang; Jian Guan; Jun Gao; Junji Wei; Yong Yao; Wei Lian; Zhiqin Xu; Wanchen Dou; Bing Xing; Zuyuan Ren; Changbao Su; Yi Yang; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.